Endothelial Progenitor Cells as a Therapeutic Option in Peripheral Arterial Disease
Authors:
- K.A. LaughlanKLK.A. Laughlan
- H.R.S. GirnHGH.R.S. Girn
- S. Homer-VanniasinkamSHS. Homer-Vanniasinkam
- 1 October 2009
- journal article
- review article
- Published by Elsevier in European Journal of Vascular and Endovascular Surgery
- Vol. 38 (4) , 475-481
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- Level and Value of Circulating Endothelial Progenitor Cells in Patients After Acute Ischemic StrokeStroke, 2008
- Clinical study of therapeutic angiogenesis by autologous peripheral blood stem cell (PBSC) transplantation in 92 patients with critically ischemic limbsJournal of Artificial Organs, 2006
- Safety and Feasibility of Transendocardial Autologous Bone Marrow Cell Transplantation in Patients With Advanced Heart DiseaseThe American Journal of Cardiology, 2006
- Influence of Cardiovascular Risk Factors on Endothelial Progenitor CellsArteriosclerosis, Thrombosis, and Vascular Biology, 2006
- Mobilizing Endothelial Progenitor CellsHypertension, 2005
- Hepatocyte growth factor induces angiogenesis in injured lungs through mobilizing endothelial progenitor cellsBiochemical and Biophysical Research Communications, 2004
- Profoundly Reduced Neovascularization Capacity of Bone Marrow Mononuclear Cells Derived From Patients With Chronic Ischemic Heart DiseaseCirculation, 2004
- Therapeutic stem and progenitor cell transplantation for organ vascularization and regenerationNature Medicine, 2003
- Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI)Circulation, 2002
- Multilineage Cells from Human Adipose Tissue: Implications for Cell-Based TherapiesTissue Engineering, 2001